Beam Therapeutics to Participate in the Chardan Virtual 5th Annual Genetic Medicines ConferenceGlobeNewsWire • 09/28/21
Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV InfectionBenzinga • 09/27/21
Beam Therapeutics Announces Preclinical Data Highlighting Potential of Base Editors to Target Disease Drivers of Chronic Hepatitis B InfectionGlobeNewsWire • 09/27/21
Beam Therapeutics' Formulated LNP Show Tolerance, Early Storage Stability In Animal StudiesBenzinga • 09/23/21
Beam Therapeutics Announces Updated Preclinical Data Highlighting Optimized LNP Delivery Approaches for In Vivo Base Editing to the Liver and Other TissuesGlobeNewsWire • 09/23/21
Could a Recent Gene Editing Breakthrough Make This Cathie Wood Stock a Buy?The Motley Fool • 09/12/21
Beam Therapeutics to Participate in the 2021 Wells Fargo Virtual Healthcare ConferenceGlobeNewsWire • 09/08/21
Beam Therapeutics Provides Business and Pipeline Updates and Reports Second Quarter 2021 Financial ResultsGlobeNewsWire • 08/10/21
Beam Therapeutics Inc. (BEAM) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 08/04/21
Beam Therapeutics to Participate in the 2021 Wedbush PacGrow Healthcare ConferenceGlobeNewsWire • 08/03/21
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This WeekThe Motley Fool • 07/16/21
Beam Therapeutics to Participate in the 2021 William Blair Biotech Focus ConferenceGlobeNewsWire • 07/08/21
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the CenturyInvestorPlace • 07/01/21